GlassScriptPhysician profile
Ryan Burns Elliott
NPI 1134530959
$7,261.94
in general payments reported to CMS, 2019-2025
28 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,100 · 2020: $534 · 2021: $341 · 2022: $316 · 2023: $1,374 · 2024: $1,426 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,970.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,724.32 | 2019-2025 | Icefx Cryoablation System, Embold Fibered, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Inari Medical, INC. | $1,212.12 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $453.37 | 2020-2024 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Atlas |
| Shockwave Medical, INC | $439.78 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $257.86 | 2024-2025 | Emprint, In.Pact Av, Symplicity G3 |
| Penumbra, INC. | $164.90 | 2025 | Indigo System |
| Stryker Corporation | $149.06 | 2025 | Flowtriever, Clottriever Bold Catheter, Artix Mt |
| Cardiovascular Systems INC. | $143.36 | 2020-2022 | |
| Abiomed | $92.67 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.25 | 2024-2025 | Lifevest |
| Philips North America LLC | $51.03 | 2023 | |
| W. L. Gore & Associates, INC. | $50.64 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $46.60 | 2024 | |
| Amarin Pharma, INC. | $44.78 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $37.30 | 2022-2023 | Xarelto |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $37.00 | 2022-2024 | Alphavac |
| Siemens Medical Solutions USA, INC. | $33.24 | 2020-2025 | Artis Q Floor |
| Becton, Dickinson and Company | $30.80 | 2024 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Teleflex LLC | $30.60 | 2023-2024 | Guideliner |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.65 | 2023 | Jardiance |
| Terumo Medical Corporation | $23.94 | 2024 | Azur Cx Detachable |
| Impulse Dynamics (USA) INC. | $23.71 | 2023 | Optimizer |
| Sirtex Medical INC | $23.71 | 2024 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Pfizer INC. | $19.64 | 2020 | |
| Chiesi USA, INC. | $17.87 | 2020 | |
| Balt USA, LLC | $17.18 | 2023 | Prestige Coil System |
| Astrazeneca Pharmaceuticals LP | $12.71 | 2023 | Brilinta |
| Edwards Lifesciences Corporation | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.